Literature DB >> 11799104

Kinetic characterization of compound I formation in the thermostable cytochrome P450 CYP119.

David G Kellner1, Shao-Ching Hung, Kara E Weiss, Stephen G Sligar.   

Abstract

The kinetics of formation and breakdown of the putative active oxygenating intermediate in cytochrome P450, a ferryl-oxo-(pi) porphyrin cation radical (Compound I), have been analyzed in the reaction of a thermostable P450, CYP119, with meta-chloroperoxybenzoic acid (m-CPBA). Upon rapid mixing of m-CPBA with the ferric form of CYP119, an intermediate with spectral features characteristic of a ferryl-oxo-(pi) porphyrin cation radical was clearly observed and identified by the absorption maxima at 370, 610, and 690 nm. The rate constant for the formation of Compound I was 3.20 (+/-0.3) x 10(5) m(-1) s(-1) at pH 7.0, 4 degrees C, and this rate decreased with increasing pH. Compound I of CYP119 decomposed back to the ferric form with a first order rate constant of 29.4 +/- 3.4 s(-1), which increased with increasing pH. These findings form the first kinetic analysis of Compound I formation and decay in the reaction of m-CPBA with ferric P450.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11799104     DOI: 10.1074/jbc.C100745200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

Review 1.  The bioinorganic chemistry of iron in oxygenases and supramolecular assemblies.

Authors:  John T Groves
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-24       Impact factor: 11.205

Review 2.  Hydroperoxoferric heme intermediate as a second electrophilic oxidant in cytochrome P450-catalyzed reactions.

Authors:  Shengxi Jin; Thomas A Bryson; John H Dawson
Journal:  J Biol Inorg Chem       Date:  2004-07-29       Impact factor: 3.358

3.  Chemistry. Glimpsing the critical intermediate in cytochrome P450 oxidations.

Authors:  Stephen G Sligar
Journal:  Science       Date:  2010-11-12       Impact factor: 47.728

4.  Molecular probes of the mechanism of cytochrome P450. Oxygen traps a substrate radical intermediate.

Authors:  Harriet L R Cooper; John T Groves
Journal:  Arch Biochem Biophys       Date:  2010-11-12       Impact factor: 4.013

5.  Cytochrome p450 compound I.

Authors:  Martin Newcomb; Rui Zhang; R Esala P Chandrasena; James A Halgrimson; John H Horner; Thomas M Makris; Stephen G Sligar
Journal:  J Am Chem Soc       Date:  2006-04-12       Impact factor: 15.419

6.  Compound I is the reactive intermediate in the first monooxygenation step during conversion of cholesterol to pregnenolone by cytochrome P450scc: EPR/ENDOR/cryoreduction/annealing studies.

Authors:  Roman Davydov; Andrey A Gilep; Natallia V Strushkevich; Sergey A Usanov; Brian M Hoffman
Journal:  J Am Chem Soc       Date:  2012-10-05       Impact factor: 15.419

7.  An FeIV=O complex of a tetradentate tripodal nonheme ligand.

Authors:  Mi Hee Lim; Jan-Uwe Rohde; Audria Stubna; Michael R Bukowski; Miquel Costas; Raymond Y N Ho; Eckard Munck; Wonwoo Nam; Lawrence Que
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-18       Impact factor: 11.205

8.  Stabilization and characterization of a heme-oxy reaction intermediate in inducible nitric-oxide synthase.

Authors:  Jesús Tejero; Ashis Biswas; Zhi-Qiang Wang; Richard C Page; Mohammad Mahfuzul Haque; Craig Hemann; Jay L Zweier; Saurav Misra; Dennis J Stuehr
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

9.  Kinetic isotope effects in hydroxylation reactions effected by cytochrome P450 compounds I implicate multiple electrophilic oxidants for P450-catalyzed oxidations.

Authors:  Xin Sheng; Haoming Zhang; Paul F Hollenberg; Martin Newcomb
Journal:  Biochemistry       Date:  2009-02-24       Impact factor: 3.162

10.  Characterization of the peroxidase mechanism upon reaction of prostacyclin synthase with peracetic acid. Identification of a tyrosyl radical intermediate.

Authors:  Hui-Chun Yeh; Gary J Gerfen; Jinn-Shyan Wang; Ah-Lim Tsai; Lee-Ho Wang
Journal:  Biochemistry       Date:  2009-02-10       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.